Skip to main content
. 2022 Mar 31;12:833884. doi: 10.3389/fonc.2022.833884

Figure 2.

Figure 2

Changes of intrahepatic lesions in the included patients after systemic treatment. [(A) TKIs group; (B) TKIs + ICIs group; PD, progressive disease; PR, partial response partial remission; ordinate, the sum of the maximum diameter of the tumor target lesion; abscissa, all patients included in this study)].